Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-09 · accession 0001209191-24-003236 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-13 | 2024-02-09 | RXRX | Marriott Tina | Pres, COO | F - Tax | $10.09 | -2,800 | 645.4K | -0.4% | -$28.3K |
| DM | 2024-02-13 | 2024-02-09 | RXRX | Marriott Tina | Pres, COO | A - Grant | $0.00 | +233.6K | 424.2K | +123% | $0 |
| D | 2024-02-13 | 2024-02-09 | RXRX | Marriott Tina | Pres, COO | A - Grant | $0.00 | +447.9K | 447.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-02-09 | F | D | 2,800 | $10.09 | 645,361 | D | — | — | |
| 2 | Common | Class A Common Stock | 2024-02-09 | A | A | 223,958 | $0.00 | 648,161 | D | — | — | |
| 3 | Common | Class A Common Stock | 2024-02-09 | A | A | 9,655 | $0.00 | 424,203 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-02-09 | A | A | 447,917 | $0.00 | 447,917 | D | $10.09 · — to 2034-02-09 | 447,917 Class A Common Stock | (F8) The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. |